Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence

Pediatric Hematology and Oncology

Volumn 33, Issue 3, 2016, Pages 157-167

  Gharbi, Hanene ^a   Ben Hassine, Islem ^a   Soltani, Ismail ^a   Safra, Ines ^a   Ouerhani, Slah ^a   Bel Haj Othmen, Hind ^a   Teber, Mouheb ^a   Farah, Ahlem ^a   Amouri, Hassiba ^a   Toumi, Nourel Houda ^b   Abdennebi, Salima ^c   Abbes, Salem ^a   Menif, Samia ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b CHILDREN S HOSPITAL   (Tunisia)

^c Hopital Aziza Othmana   (Tunisia)

Author keywords

ALL; ARID5B; CDKN2A; CEBPE; IKZF1; racial differences

Indexed keywords

DNA; ARID5B PROTEIN, HUMAN; CCAAT ENHANCER BINDING PROTEIN; CDKN2A PROTEIN, HUMAN; CEBPE PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 2C; DNA BINDING PROTEIN; IKAROS TRANSCRIPTION FACTOR; IKZF1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARID5B GENE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CAUCASIAN; CDKN2A GENE; CEBPE GENE; CHILD; CHILDHOOD LEUKEMIA; CODOMINANCE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOMINANT INHERITANCE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIATION; GENOTYPE; HUMAN; IKZF1 GENE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYMERASE CHAIN REACTION; POPULATION; RACE DIFFERENCE; RECESSIVE INHERITANCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; THAI (PEOPLE); TUNISIAN; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD;

ADOLESCENT; CCAAT-ENHANCER-BINDING PROTEINS; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P18; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; IKAROS TRANSCRIPTION FACTOR; INCIDENCE; INFANT; INFANT, NEWBORN; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSCRIPTION FACTORS;

EID: 84969622720     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2016.1161685     Document Type: Article

References (27)

1. P.Kaatsch Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36:277–285
2. C.H.Pui, M.V.Relling, J.R.Downing. Acute lymphoblastic leukemia. N Engl J Med. 2004;350:1535–1548.
3. D.N.Mbanya, E.M.Minkoulou, L.N.Kaptue. HIV-1 infection in adults with haematological malignancies in Yaounde, Cameroon. West Afr J Med. 2002; 21:183–184.
4. K.Y.Urayama, A.P.Chokkalingam, A.Manabe, S.Mizutani. Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia. Int J Hematol. 2013;97:3–19.
5. J.Vijayakrishnan, R.S.Houlston. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica. 2010;95:1405–14.
6. A.L.Sherborne, F.J.Hosking, R.B.Prasad, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42:492–494.
7. L.R.Trevino, W.Yang, D.French, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1001–1005.
8. N.Harker, T.Naito, M.Cortes, et al. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell. 2002;10:1403–1415.
9. M.H.Lahoud, S.Ristevski, D.J.Venter, et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res. 2001;11:1327–1334.
10. A.Patsialou, D.Wilsker, E.Moran. DNA-binding properties of ARID family proteins. Nucleic Acids Res. 2005;33:66–80.
11. D.Wilsker, A.Patsialou, P.B.Dallas, E.Moran. ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development. Cell Growth Differ. 2002;13:95–106.
12. T.Akagi, N.H.Thoennissen, A.George, et al. In vivo deficiency of both C/EBPβ and C/EBPϵ results in highly defective myeloid differentiation and lack of cytokine response. PLoS ONE. 2010;5:e15419.
13. K.D.Robertson, P.A.Jones. Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus. Oncogene. 1999;18:3810–3820.
14. J.Ye, G.Coulouris, I.Zaretskaya, I.Cutcutache, S.Rozen, T.L.Madden. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012;13:134.
15. R.C.Team R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
16. A.Gutierrez-Camino, E.Lopez-Lopez, I.Martin-Guerrero, et al. Intron 3 of the ARID5B gene: a hot spot for acute lymphoblastic leukemia susceptibility. J Cancer Res Clin Oncol. 2013;139:1879–1886.
17. E.Papaemmanuil, F.J.Hosking, J.Vijayakrishnan, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41:1006–1010.
18. C.Y.Lin, M.J.Li, J.G.Chang, et al. High-resolution melting analyses for genetic variants in ARID5B and IKZF1 with childhood acute lymphoblastic leukemia susceptibility loci in Taiwan. Blood Cells Mol Dis. 2014;52:140–145.
19. J.Vijayakrishnan, A.L.Sherborne, R.Sawangpanich, S.Hongeng, R.S.Houlston, S.Pakakasama. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma. 2010; 51:1870–1874.
20. K.Georgopoulos, M.Bigby, J.H.Wang, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994;79:143–156.
21. A.Pastorczak, P.Gorniak, A.Sherborne, et al. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res. 2011;35:1534–1536.
22. R.B.Prasad, F.J.Hosking, J.Vijayakrishnan, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood. 2010;115:1765–1767.
23. J.A.Ross, A.M.Linabery, C.N.Blommer, et al. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer. 2013;60:31–34.
24. O.Lautner-Csorba, A.Gezsi, A.F.Semsei, et al. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. BMC Med Genomics. 2012;5:42.
25. T.Akasaka, T.Balasas, L.J.Russell, et al. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 2007;109:3451–3461.
26. L.Orsi, J.Rudant, A.Bonaventure, et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia. 2012;26:2561–2564.
27. E.Ellinghaus, M.Stanulla, G.Richter, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia. 2012;26:902–909.